Shares of PetMed Express PETS rose 3.5% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share rose 9.37% year over year to $0.35, which beat the estimate of $0.29.
Revenue of $74,286,000 rose by 15.06% year over year, which beat the estimate of $66,240,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: May 04, 2020
Time: 08:01 AM ET
Webcast URL: https://www.1800petmeds.com/investorpresentation.jsp
Technicals
52-week high: $41.59
Company's 52-week low was at $15.00
Price action over last quarter: Up 59.02%
Company Overview
PetMed Express Inc along with its and subsidiaries is a leading nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
